These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31611565)

  • 1. Development of two different formats of heterogeneous fluorescence immunoassay for bioanalysis of afatinib by employing fluorescence plate reader and KinExA 3200 immunosensor.
    Darwish IA; AlRabiah H; Hamidaddin MA
    Sci Rep; 2019 Oct; 9(1):14742. PubMed ID: 31611565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and comparative evaluation of two immunoassay platforms for bioanalysis of crizotinib: A potent drug used for the treatment of non-small cell lung cancer.
    Hamidaddin MA; AlRabiah H; Darwish IA
    Talanta; 2019 Aug; 201():217-225. PubMed ID: 31122414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of two highly sensitive and selective sensor-assisted fluorescence immunoassays for trace determination of copper residues in food samples.
    Darwish IA; Wang Z; Darling RJ; Alzoman NZ
    RSC Adv; 2023 Oct; 13(42):29195-29205. PubMed ID: 37818275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Comparative Evaluation of Two Highly Sensitive Immunosensor Platforms for Trace Determination of Copper Ions in Drinking Water Using a Monoclonal Antibody Specific to Copper-EDTA Complex.
    Darwish IA; Wang Z; Darling RJ
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an ELISA with high sensitivity for therapeutic monitoring of afatinib.
    Al-Shehri MM; El-Gendy MA; El-Azab AS; Hamidaddin MA; Darwish IA
    Bioanalysis; 2018 Sep; 10(18):1511-1523. PubMed ID: 30117333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of generic heterogeneous fluoroimmunoassay for bioanalysis of bevacizumab and cetuximab monoclonal antibodies used for cancer immunotherapy.
    Hamidaddin MA; AlRabiah H; Darwish IA
    Talanta; 2018 Oct; 188():562-569. PubMed ID: 30029413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic-exclusion analysis-based immunosensors versus enzyme-linked immunosorbent assays for measurement of cancer markers in biological specimens.
    Darwish IA; Wani TA; Alanazi AM; Hamidaddin MA; Zargar S
    Talanta; 2013 Jul; 111():13-9. PubMed ID: 23622520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated flow fluorescent noncompetitive immunoassay for measurement of human plasma levels of monoclonal antibodies used for immunotherapy of cancers with KinExA™ 3200 biosensor.
    AlRabiah H; Hamidaddin MA; Darwish IA
    Talanta; 2019 Jan; 192():331-338. PubMed ID: 30348399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of monensin in milk samples by front-surface long-wavelength fluoroimmunoassay using nile blue-doped silica nanoparticles as labels.
    Godoy-Navajas J; Aguilar-Caballos MP; Gómez-Hens A
    Talanta; 2012 May; 94():195-200. PubMed ID: 22608435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of tyrosine kinase inhibitor afatinib in rat plasma using LC-MS/MS and its application to in vivo pharmacokinetic studies of afatinib liposomes.
    Lu X; Liu S; Yang X; Han M; Sun K
    J Pharm Biomed Anal; 2019 Feb; 164():181-186. PubMed ID: 30390560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical desorption of immobilized proteins using carbon dioxide aerosols for reusable biosensors.
    Singh R; Hong S; Jang J
    Anal Chim Acta; 2015 Jan; 853():588-595. PubMed ID: 25467507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual FITC lateral flow immunoassay for sensitive detection of Escherichia coli O157:H7 in food samples.
    Song C; Liu J; Li J; Liu Q
    Biosens Bioelectron; 2016 Nov; 85():734-739. PubMed ID: 27266657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of hapten, generation of specific polyclonal antibody and development of ELISA with high sensitivity for therapeutic monitoring of crizotinib.
    Al-Shehri MM; El-Azab AS; El-Gendy MA; Hamidaddin MA; Darwish IA
    PLoS One; 2019; 14(2):e0212048. PubMed ID: 30742664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Layer-by-layer multienzyme assembly for highly sensitive electrochemical immunoassay based on tyramine signal amplification strategy.
    Zhou J; Tang J; Chen G; Tang D
    Biosens Bioelectron; 2014 Apr; 54():323-8. PubMed ID: 24291751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-based sensors for heavy metal ions.
    Blake DA; Jones RM; Blake RC; Pavlov AR; Darwish IA; Yu H
    Biosens Bioelectron; 2001 Dec; 16(9-12):799-809. PubMed ID: 11679258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk-free simultaneous fluoroimmunoassay of two biomarkers based on dual-color quantum dots.
    Cao Z; Li H; Lau C; Zhang Y
    Anal Chim Acta; 2011 Jul; 698(1-2):44-50. PubMed ID: 21645658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sandwich-format ECL immunosensor based on Au star@BSA-Luminol nanocomposites for determination of human chorionic gonadotropin.
    Zhang A; Guo W; Ke H; Zhang X; Zhang H; Huang C; Yang D; Jia N; Cui D
    Biosens Bioelectron; 2018 Mar; 101():219-226. PubMed ID: 29096359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of zidovudine concentration in serum by enzyme-linked immunosorbent assay and by time-resolved fluoroimmunoassay.
    Tadepalli SM; Quinn RP
    J Acquir Immune Defic Syndr (1988); 1990; 3(1):19-27. PubMed ID: 2293639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective binding of polychlorinated biphenyl congeners by a monoclonal antibody: analysis by kinetic exclusion fluorescence immunoassay.
    Chiu YW; Li QX; Karu AE
    Anal Chem; 2001 Nov; 73(22):5477-84. PubMed ID: 11816577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer.
    Yonesaka K; Kudo K; Nishida S; Takahama T; Iwasa T; Yoshida T; Tanaka K; Takeda M; Kaneda H; Okamoto I; Nishio K; Nakagawa K
    Oncotarget; 2015 Oct; 6(32):33602-11. PubMed ID: 26418897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.